Part of our patient advocacy often includes helping people get a diagnosis for symptoms that medical providers might not easily recognize. Whether you have heard of it yet or not, Ehlers-Danlos syndromes (EDS), especially hypermobile EDS (hEDS) or Hypermobile Spectrum Disorder (HSD), are among the most underdiagnosed, misunderstood, and misattributed conditions akin to multiple sclerosis with unknown origin and long diagnostic journeys. Led by Christie Cox, BCPA, an APHA member, author and advocate for the Ehlers-Danlos community.
This session has been approved for 1 General CE by the Patient Advocate Certification Board.
Thank you for attending our session. Your feedback helps us ensure quality and continuous improvement.
Please take a moment to complete this brief evaluation.
Originally presented May 6, 2025.
Continuing Education (CE) Credit Validity Period: This webinar is eligible for CE credit for two years from the date of the original live presentation. After that date, the recording may remain available for educational purposes but will no longer be eligible for CE credit.